171 related articles for article (PubMed ID: 11345771)
1. [Prediction of effect of beta-blocker therapy in patients with dilated cardiomyopathy by using 123I-BMIPP, 123I-MIBG scintigraphy].
Inoue A; Yamazaki J; Nanjou S; Togane Y; Amano H
Kaku Igaku; 2001 Mar; 38(2):99-104. PubMed ID: 11345771
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of beta-blocker therapy in patients with dilated cardiomyopathy--Clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography.
Yamazaki J; Muto H; Kabano T; Yamashina S; Nanjo S; Inoue A
Am Heart J; 2001 Apr; 141(4):645-52. PubMed ID: 11275933
[TBL] [Abstract][Full Text] [Related]
3. [Usefulness of 123I-MIBG scintigraphy for prediction of effect of beta-blocker therapy in dilated cardiomyopathy].
Tawarahara K; Sugiyama T; Nakano T; Matou F; Kurata C; Wakabayashi Y; Shouda S; Mikami T
Kaku Igaku; 1998 Jul; 35(6):413-20. PubMed ID: 9753920
[TBL] [Abstract][Full Text] [Related]
4. Predicting the effects on patients with dilated cardiomyopathy of beta-blocker therapy, by using iodine-123 15-(p-iodophenyl)-3- R,S-methylpentadecanoic acid (BMIPP) myocardial scintigraphy.
Yoshinaga K; Tahara M; Torii H; Kihara K
Ann Nucl Med; 1998 Dec; 12(6):341-7. PubMed ID: 9972371
[TBL] [Abstract][Full Text] [Related]
5. Use of iodine-123 metaiodobenzylguanidine myocardial imaging to predict the effectiveness of beta-blocker therapy in patients with dilated cardiomyopathy.
Fukuoka S; Hayashida K; Hirose Y; Shimotsu Y; Ishida Y; Kakuchi H; Eto T
Eur J Nucl Med; 1997 May; 24(5):523-9. PubMed ID: 9142733
[TBL] [Abstract][Full Text] [Related]
6. Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to beta-blocker therapy in patients with dilated cardiomyopathy.
Suwa M; Otake Y; Moriguchi A; Ito T; Hirota Y; Kawamura K; Adachi I; Narabayashi I
Am Heart J; 1997 Mar; 133(3):353-8. PubMed ID: 9060806
[TBL] [Abstract][Full Text] [Related]
7. Recovery of the cardiac adrenergic nervous system after long-term beta-blocker therapy in idiopathic dilated cardiomyopathy: assessment by increase in myocardial 123I-metaiodobenzylguanidine uptake.
Lotze U; Kaepplinger S; Kober A; Richartz BM; Gottschild D; Figulla HR
J Nucl Med; 2001 Jan; 42(1):49-54. PubMed ID: 11197980
[TBL] [Abstract][Full Text] [Related]
8. Relationship between evaluation by quantitative fatty acid myocardial scintigraphy and response to beta-blockade therapy in patients with dilated cardiomyopathy.
Ito T; Hoshida S; Nishino M; Aoi T; Egami Y; Takeda T; Kawabata M; Tanouchi J; Yamada Y; Kamada T
Eur J Nucl Med; 2001 Dec; 28(12):1811-6. PubMed ID: 11734920
[TBL] [Abstract][Full Text] [Related]
9. Prediction of cardiac events in patients with dilated cardiomyopathy using 123I-BMIPP and 201Tl myocardial scintigraphy.
Inoue A; Fujimoto S; Yamashina S; Yamazaki J
Ann Nucl Med; 2007 Sep; 21(7):399-404. PubMed ID: 17876553
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of 123I-metaiodobenzylguanidine myocardial scintigraphy for predicting the effectiveness of beta-blockers in patients with dilated cardiomyopathy from the standpoint of long-term prognosis.
Fujimoto S; Inoue A; Hisatake S; Yamashina S; Yamashina H; Nakano H; Yamazaki J
Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1356-61. PubMed ID: 15221293
[TBL] [Abstract][Full Text] [Related]
11. [Two cases of dilated cardiomyopathy with the relationship between the effect of beta-blocker therapy and the changes of myocardial clearance of 123I-metaiodobenzylguanidine].
Momose M; Kobayashi H; Saito K; Horie T; Maki M; Hosoda S; Kusakabe K
Kaku Igaku; 1995 Mar; 32(3):301-6. PubMed ID: 7739160
[TBL] [Abstract][Full Text] [Related]
12. [Usefulness of 123I-MIBG and 123I-BMIPP myocardial scintigraphy for detecting coronary artery disease and for evaluating left ventricular function].
Toyama T; Suzuki Y; Tsukagoshi J; Kanda T; Imai S; Murata K; Tateno M; Endo K; Suzuki T; Hoshizaki H
Kaku Igaku; 1995 Feb; 32(2):173-81. PubMed ID: 7715103
[TBL] [Abstract][Full Text] [Related]
13. Cardiac sympathetic activity estimated by 123I-MIBG myocardial imaging in patients with dilated cardiomyopathy after beta-blocker or angiotensin-converting enzyme inhibitor therapy.
Toyama T; Aihara Y; Iwasaki T; Hasegawa A; Suzuki T; Nagai R; Endo K; Hoshizaki H; Oshima S; Taniguchi K
J Nucl Med; 1999 Feb; 40(2):217-23. PubMed ID: 10025826
[TBL] [Abstract][Full Text] [Related]
14. [Clinical meaning of 123I-MIBG myocardial SPeCT in patients with dilated cardiomyopathy].
Yamazaki J; Hosoi H; Yamashina H; Kabano T; Yamashina S; Nanjo S; Matsukawa S; Morishita T; Okamoto K; Ohsawa H
Kaku Igaku; 1994 Apr; 31(4):373-7. PubMed ID: 8196234
[TBL] [Abstract][Full Text] [Related]
15. Myocardial scintigraphy using iodine-123 15-(p-iodophenyl)-3-R, S-methylpentadecanoic acid predicts the response to beta-blocker therapy in patients with dilated cardiomyopathy but does not reflect therapeutic effect.
Yoshinaga K; Tahara M; Torii H; Akimoto M; Kihara K; Tei C
J Cardiol; 2000 May; 35(5):343-51. PubMed ID: 10834178
[TBL] [Abstract][Full Text] [Related]
16. [The relationship between the improvement of cardiac function and the myocardial uptake of I-123 metaiodobenzylguanidine in patients with dilated cardiomyopathy treated by beta-blocker].
Wakita T; Numata Y; Ogata Y; Harada E; Mizumasa Y
J Cardiol; 1995 Sep; 26(3):177-83. PubMed ID: 7473048
[TBL] [Abstract][Full Text] [Related]
17. Quantitative scintigraphic analysis of 123I-MIBG by polar map in patients with dilated cardiomyopathy.
Yamazaki J; Muto H; Ishiguro S; Okamoto K; Hosoi H; Nakano H; Morishita T
Nucl Med Commun; 1997 Mar; 18(3):219-29. PubMed ID: 9106775
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of meta-[123I]iodobenzylguanidine myocardial scintigraphy for predicting cardiac events in patients with dilated cardiomyopathy who receive long-term beta blocker treatment.
Fujimoto S; Inoue A; Hisatake S; Yamashina S; Yamashina H; Nakano H; Yamazaki J
Nucl Med Commun; 2005 Feb; 26(2):97-102. PubMed ID: 15657500
[TBL] [Abstract][Full Text] [Related]
19. Myocardial sympathetic denervation, fatty acid metabolism, and left ventricular wall motion in vasospastic angina.
Watanabe K; Takahashi T; Miyajima S; Hirokawa Y; Tanabe N; Kato K; Kodama M; Aizawa Y; Tazawa S; Inoue M
J Nucl Med; 2002 Nov; 43(11):1476-81. PubMed ID: 12411551
[TBL] [Abstract][Full Text] [Related]
20. Creatine depletion and altered fatty acid metabolism in diseased human hearts: clinical investigation using 1H magnetic resonance spectroscopy and 123I BMIPP myocardial scintigraphy.
Nakae I; Mitsunami K; Matsuo S; Horie M
Acta Radiol; 2007 May; 48(4):436-43. PubMed ID: 17453526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
